TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$65.28
−1.89%Margins
Gross margin
94.4%
EBITDA margin
0.3%
EBIT margin
-6.8%
Net margin
-7.4%
FCF margin
8.7%
-177.2%
Return on equity
-5.4%
Return on assets
-6.3%
Return on invested capital
0.87x
Asset turnover
$92.7M
Cash from operations
$5.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026